| dbo:abstract
|
- Ming-Ming Zhou, Ph.D., is an expert in structural and chemical biology, NMR spectroscopy and drug design. He is currently the Dr. Harold and Golden Lamport Professor and Chairman of the Department of Pharmacological Sciences and Co-Director of the Drug Discovery Institute at the Icahn School of Medicine at Mount Sinai and Mount Sinai Health System in New York City as well as Professor of Oncological Sciences. Zhou has published more than 180 research articles and is an inventor of 28 patents. His research has been funded by grants from federal, state and private research foundations including the National Institutes of Health, the National Science Foundation, the New York State Stem Cell Science, the Institute for the Study of Aging, the American Foundation for AIDS Research, the American Cancer Society, GlaxoSmithKline, the Michael J. Fox Foundation, the Samuel Waxman Cancer Research Foundation, and the Wellcome Trust. He serves on the Board of Directors at the New York Structural Biology Center, as well as on the editorial boards of ACS Medicinal Chemistry Letters, the Journal of Molecular Cell Biology and Cancer Research. Zhou received the GlaxoSmithKline Drug Discovery Research Award in 2003 for his work in anti-HIV/AIDS therapy development, and the Jacobi Medallion in 2019. He is an elected fellow of the American Association for the Advancement of Science (2012). (en)
|
